MEPRONIZINE Side Effects

6583637-3 | Coma, Hypokalaemia, Pyrexia
on Feb 01, 2010 Female patient from FRANCE , 63 years of age, was treated with Mepronizine (View Usage). Patient experienced the following unwanted or unexpected effects: coma, hypokalaemia, pyrexia. Mepronizine dosage: . During the same period patient was treated with STILNOX (View Stilnox Review and Stilnox Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), NORSET (View Norset Review and Norset Label ).

5707959-0 | Condition Aggravated, Leukocytosis, Neutrophilia
Patient was taking Mepronizine (View Usage). Patient had the following side effects: condition aggravated, leukocytosis, neutrophilia on Apr 11, 2008 from FRANCE Additional patient health information: Male patient , 38 years of age, . Mepronizine dosage: . During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), STILNOX (View Stilnox Review and Stilnox Label ), LEPONEX (From 50 To 400 Mg/day) (View Leponex Review and Leponex Label ). Patient was hospitalized.

5648499-7 | Condition Aggravated, Leukocytosis, Myeloproliferative Disorder, Neutrophilia
Adverse event was reported on Feb 25, 2008 by a Male patient taking Mepronizine (View Usage) (Dosage: ) . Location: FRANCE , 38 years of age, After Mepronizine was administered, patient had the following side effects: condition aggravated, leukocytosis, myeloproliferative disorder, neutrophilia. During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), STILNOX (View Stilnox Review and Stilnox Label ), LEPONEX (From 50 To 400 Mg/day) (View Leponex Review and Leponex Label ). Patient was hospitalized.

4876008-9 | Acute Respiratory Failure, Bronchitis, Fall, Hypotension, Inflammation, Leukocytosis, Malaise, Right Ventricular Failure
on Dec 28, 2005 Female patient from FRANCE , 81 years of age, weighting 132.3 lb, was treated with Mepronizine (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, bronchitis (What is bronchitis?), fall (What is fall?), hypotension, inflammation, leukocytosis, malaise, right ventricular failure. Mepronizine dosage: . During the same period patient was treated with ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), XANAX (View Xanax Review and Xanax Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PREVISCAN (Unk) (View Previscan Review and Previscan Label ), AMLOR (View Amlor Review and Amlor Label ), LASILIX (View Lasilix Review and Lasilix Label ), DISCOTRINE (View Discotrine Review and Discotrine Label ). Patient was hospitalized.


4695866-4 | Dyskinesia, Dysstasia, Fall, Headache, Hyperhidrosis, Hypertension, Insomnia, Muscle Rigidity
on Jun 09, 2005 Female patient from , 60 years of age, was diagnosed with depression (What is depression?) and was treated with Mepronizine (View Usage). Patient had the following side effects: dyskinesia, dysstasia, fall (What is fall?), headache (What is headache?), hyperhidrosis, hypertension, insomnia, muscle rigidity. Mepronizine dosage: . During the same period patient was treated with STILNOX (View Stilnox Review and Stilnox Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), TEMESTA (Unk) (View Temesta Review and Temesta Label ), PROPOFOL (Unk) (View Propofol Review and Propofol Label ). Patient was hospitalized.

4666561-2 | Hyperkalaemia, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Pneumonia
Patient was taking Mepronizine (View Usage). After Mepronizine was administered, patient had the following side effects: hyperkalaemia, hyponatraemia, inappropriate antidiuretic hormone secretion, pneumonia (What is pneumonia?) on Nov 25, 2004 from Additional patient health information: Male patient , 32 years of age, weighting 249.1 lb, . Mepronizine dosage: . During the same period patient was treated with MODECATE (Unk) (View Modecate Review and Modecate Label ), VICTAN (View Victan Review and Victan Label ), STILNOX (Unk) (View Stilnox Review and Stilnox Label ), DEPAKENE (View Depakene Review and Depakene Label ), ISOPTIN (Unk) (View Isoptin Review and Isoptin Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

4557173-X | Fluid Replacement, Renal Failure Acute
Adverse event was reported on Jan 11, 2005 by a Female patient taking Mepronizine (View Usage) (Dosage: 1 Df, Qd) was diagnosed with metastases to bone and. Location: , 55 years of age, Patient experienced the following unwanted or unexpected effects: fluid replacement, renal failure acute. During the same period patient was treated with SOPHIDONE (8 Mg, Qd) (View Sophidone Review and Sophidone Label ), EQUANIL (250 Mg, Qd) (View Equanil Review and Equanil Label ), LASILIX (60 Mg, Qd) (View Lasilix Review and Lasilix Label ), SOLU MEDROL (120 Mg, Tid) (View Solu-medrol Review and Solu-medrol Label ), AREDIA (90 Mg, Qmo) (View Aredia Review and Aredia Label ).

4554330-3 | Fluid Replacement, Renal Failure Acute
on Jan 11, 2005 Female patient from , 55 years of age, was diagnosed with metastases to bone and was treated with Mepronizine (View Usage). Patient had the following side effects: fluid replacement, renal failure acute. Mepronizine dosage: 1 Df, Qd. During the same period patient was treated with SOPHIDONE (8 Mg, Qd) (View Sophidone Review and Sophidone Label ), EQUANIL (250 Mg, Qd) (View Equanil Review and Equanil Label ), LASILIX (60 Mg, Qd) (View Lasilix Review and Lasilix Label ), SOLU MEDROL (120 Mg, Tid) (View Solu-medrol Review and Solu-medrol Label ), AREDIA (90 Mg, Qmo) (View Aredia Review and Aredia Label ).